TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/22/22 16:19 | 2/17/22 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Jatin | MA | O | EVP,Chie | S | -16 | 12.12 | 0 | -1 | -1 | 129 | D | ||||||||||||||
2/9/22 17:27 | 2/7/22 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Jatin | MA | O | EVP,Chie | S | -17 | 9.86 | 0 | -2 | -1 | 131 | D | ||||||||||||||
2/22/21 20:12 | 2/18/21 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Jatin | MA | O | EVP,Chie | S | -18 | 14.83 | 0 | -1 | -2 | 52 | D | ||||||||||||||
2/17/21 18:48 | 2/11/21 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Jatin | MA | O | EVP,Chie | S.d | -27 | 15.52 | 0 | -2 | -3 | 53 | D | ||||||||||||||
11/4/20 20:16 | 7/15/20 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Jatin | MA | O | EVP,Chie | S.d | -11 | 19.46 | 0 | -1 | -1 | 43 | D | ||||||||||||||
2/21/20 17:58 | 2/19/20 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Jatin | MA | O | EVP,Chie | S | -23 | 16.48 | 0 | -1 | -3 | 41 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |